Articles that cite this article

The Telmisartan Renoprotective Study from Incipient Nephropathy to Overt Nephropathy - Rationale, Study Design, Treatment Plan and Baseline Characteristics of the Incipient to Overt: Angiotensin II Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study

Authors: Makino, H.; Haneda, M.; Babazono, T.; Moriya, T.; Ito, S.; Iwamoto, Y.; Kawamori, R.; Takeuchi, M.; Katayama, S.

Source: The Journal of International Medical Research, Volume 33, Number 6, November 2005 , pp. 677-686(10)

Publisher: Field House Publishing